James Harrison’s legacy is at the heart of a wild story about canny science, boundless goodwill and an errant blood ...

Immunome's strong financial position supports ongoing clinical development and potential market entry for key assets. See why ...

We look at some recent studies that use organ-on-a-chip models to provide insights into human biology and drug.

NU-9 targets a shared underlying mechanism found in various neurodegenerative diseases. A new study from Northwestern ...

B cells can produce high-affinity antibodies and generate immunological memory. Adenoids and tonsils in children can become hypertrophic because of multiple infections. Here the authors use single ...

The following is a summary of “Recall vaccination increases detectable B-cell reactivity in persons with multiple sclerosis treated with ocrelizumab,” published in the April 2025 issue of Journal of ...

Technological advances empower the modification of NK cells and renewed potential for therapeutic uses in cancer and ...

In animal models, NU-9 was found to show promise in treating Alzheimer's by reducing toxic protein buildup and brain ...

Three doses of COVID-19 mRNA vaccination induce long-lasting antibody and memory B-cell responses, according to a study of ...

Three doses of COVID-19 mRNA vaccination induce long-lasting antibody and memory B-cell responses, according to a study of 113 healthcare workers in Catalonia who were followed during three years. The ...

Experimental drug NU-9 - a small molecule compound approved by the U.S. Food and Drug Administration (FDA) for clinical trials for the treatment of amyotrophic lateral sclerosis (ALS) - improves ...